Literature DB >> 20981258

Direct vasocontractile activities of bupivacaine enantiomers on the isolated rat thoracic aorta.

Mai Mukozawa1, Ko Takakura, Maki Mizogami.   

Abstract

Background. In vitro studies with isolated arteries have shown direct vasoactivity of racemic bupivacaine. However, there is little information on the direct vasoactivities of bupivacaine enantiomers, S(-)- and R(+)-bupivacaine. Methods. We performed functional examinations using isolated intact thoracic aortic rings from male Wistar rats. Changes in ring tension produced by S(-)-, R(+)-, or racemic bupivacaine were measured in Krebs solution. Results. S(-)-bupivacaine produced the strongest contraction of the three agents. R(+)-bupivacaine showed limited vasoconstriction. The effects of racemic bupivacaine were located between these two. Conclusion. Each bupivacaine enantiomer showed specific vasocontractile activity, which affects the activity of racemic bupivacaine.

Entities:  

Year:  2010        PMID: 20981258      PMCID: PMC2964006          DOI: 10.1155/2010/820186

Source DB:  PubMed          Journal:  Anesthesiol Res Pract        ISSN: 1687-6962


  16 in total

1.  Skin blood flow changes in response to intradermal injection of bupivacaine and levobupivacaine, assessed by laser Doppler imaging.

Authors:  D J Newton; D Burke; F Khan; G A McLeod; J J Belch; M McKenzie; J Bannister
Journal:  Reg Anesth Pain Med       Date:  2000 Nov-Dec       Impact factor: 6.288

Review 2.  Drug chirality in anesthesia.

Authors:  Carla Nau; Gary R Strichartz
Journal:  Anesthesiology       Date:  2002-08       Impact factor: 7.892

3.  Vasoactive characteristics of bupivacaine and levobupivacaine with and without adjuvant epinephrine in peripheral human skin.

Authors:  D J Newton; G A McLeod; F Khan; J J F Belch
Journal:  Br J Anaesth       Date:  2005-02-18       Impact factor: 9.166

4.  Effects of bupivacaine and calcium antagonists on the rat uterine artery.

Authors:  H Norén; B Lindblom; B Källfelt
Journal:  Acta Anaesthesiol Scand       Date:  1991-01       Impact factor: 2.105

5.  Effect of epinephrine on epidural, intrathecal, and plasma pharmacokinetics of ropivacaine and bupivacaine in sheep.

Authors:  M Ratajczak-Enselme; J-P Estebe; F-X Rose; E Wodey; J-M Malinovsky; F Chevanne; G Dollo; C Ecoffey; P Le Corre
Journal:  Br J Anaesth       Date:  2007-10-23       Impact factor: 9.166

6.  Stereospecific interaction of bupivacaine enantiomers with lipid membranes.

Authors:  Maki Mizogami; Hironori Tsuchiya; Takahiro Ueno; Masanori Kashimata; Ko Takakura
Journal:  Reg Anesth Pain Med       Date:  2008 Jul-Aug       Impact factor: 6.288

7.  Dose-dependent effects of bupivacaine on rat muscle arterioles.

Authors:  R A Johns; W C Seyde; C A DiFazio; D E Longnecker
Journal:  Anesthesiology       Date:  1986-08       Impact factor: 7.892

8.  Peroxynitrite decreases dopamine's vasoconstrictive activity.

Authors:  Ko Takakura; Wen Xiaohong; Kenji Takeuchi; Satoru Fukuda
Journal:  Anesth Analg       Date:  2003-11       Impact factor: 5.108

9.  An intradermal study of the local anaesthetic and vascular effects of the isomers of bupivacaine.

Authors:  C Aps; F Reynolds
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

10.  Smooth muscle effects of lidocaine, prilocaine, bupivacaine and etiodocaine on the human umbilical artery.

Authors:  T Tuvemo; G Willdeck-Lund
Journal:  Acta Anaesthesiol Scand       Date:  1982-04       Impact factor: 2.105

View more
  2 in total

1.  Differential effects of short- and long-term bupivacaine treatment on α1-adrenoceptor-mediated contraction of isolated rat aorta rings and the reversal effect of lipid emulsion.

Authors:  Hao Guo; He-fei Zhang; Wen-qi Xu; Qian Du; Jing Zhao; Lei-ming Ren
Journal:  Acta Pharmacol Sin       Date:  2015-06-15       Impact factor: 6.150

Review 2.  Chiral Aspects of Local Anesthetics.

Authors:  Ružena Čižmáriková; Jozef Čižmárik; Jindra Valentová; Ladislav Habala; Mário Markuliak
Journal:  Molecules       Date:  2020-06-12       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.